Market Place
Sourcing Support
Eris Launches Weekly Semaglutide Shot At ?220/Shot
20 Mar 2026 //
EXPRESSPHARMA
Eris, Natco Pharma Partner For Semaglutide Launch In India
25 Feb 2026 //
INDPHARMAPOST
CDSCO OKs Most New r-DNA Drugs for 2025 Import & Manufacture
21 Jan 2026 //
PHARMABIZ
Delhi HC Restores Ban On 2 Diabetes FDCs
14 Jan 2026 //
ECONOMICTIMES
Eris Lifesciences Consolidates Its Stake In Swiss Parenterals
25 Nov 2025 //
INDPHARMAPOST
Indian Pharma Prepares For ?600-800 Cr Insulin Pen Market
22 Sep 2025 //
BUSINESS STD
Eris Lifesciences Secures ANVISA Approval at Ahmedabad Campus
25 Aug 2025 //
INDPHARMAPOST
Eris Lifesciences Eyes ‘good’ Share in Semaglutide Generics
05 Aug 2025 //
ECONOMICTIMES
Eris Lifesciences Reports 41% Rise in Net Profit in Q1 Earnings
05 Aug 2025 //
ECONOMICTIMES
Domestic drug firms benefit as global players seek new markets
20 May 2025 //
ECONOMICTIMES
Eris Lifesciences appoints Gopal Agrawal, Nita Borkar to leadership
02 Apr 2025 //
EXPRESSPHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.